- Home
- ZVRA vs GAIN Comparison
ZVRA vs GAIN Comparison
Compare ZVRA & GAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVRA
- GAIN
- Stock Information
- Founded
- ZVRA 2006
- GAIN 2005
- Country
- ZVRA United States
- GAIN United States
- Employees
- ZVRA N/A
- GAIN N/A
- Industry
- ZVRA Biotechnology: Pharmaceutical Preparations
- GAIN Finance: Consumer Services
- Sector
- ZVRA Health Care
- GAIN Finance
- Exchange
- ZVRA Nasdaq
- GAIN Nasdaq
- Market Cap
- ZVRA 627.7M
- GAIN 522.8M
- IPO Year
- ZVRA 2015
- GAIN 2005
- Fundamental
- Price
- ZVRA $9.02
- GAIN $14.15
- Analyst Decision
- ZVRA Strong Buy
- GAIN Hold
- Analyst Count
- ZVRA 10
- GAIN 2
- Target Price
- ZVRA $22.67
- GAIN $13.50
- AVG Volume (30 Days)
- ZVRA 1.6M
- GAIN 124.1K
- Earning Date
- ZVRA 08-12-2025
- GAIN 08-12-2025
- Dividend Yield
- ZVRA N/A
- GAIN 15.53%
- EPS Growth
- ZVRA N/A
- GAIN 8.96
- EPS
- ZVRA N/A
- GAIN 2.16
- Revenue
- ZVRA $62,020,000.00
- GAIN $95,028,000.00
- Revenue This Year
- ZVRA $329.57
- GAIN $6.70
- Revenue Next Year
- ZVRA $55.29
- GAIN $5.50
- P/E Ratio
- ZVRA N/A
- GAIN $6.55
- Revenue Growth
- ZVRA 161.81
- GAIN 6.55
- 52 Week Low
- ZVRA $6.19
- GAIN $11.42
- 52 Week High
- ZVRA $13.16
- GAIN $15.34
- Technical
- Relative Strength Index (RSI)
- ZVRA 38.21
- GAIN 53.10
- Support Level
- ZVRA $9.16
- GAIN $13.92
- Resistance Level
- ZVRA $9.48
- GAIN $14.17
- Average True Range (ATR)
- ZVRA 0.57
- GAIN 0.18
- MACD
- ZVRA -0.09
- GAIN -0.01
- Stochastic Oscillator
- ZVRA 18.99
- GAIN 41.54
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
About GAIN Gladstone Investment Corporation Business Development Company
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to achieve and grow current income by investing in debt securities of established businesses; provide the stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.